A.Nelson et al.
Bn, o-Bn), 7.18–7.08 (m, 9H; indolyl 5-H, indolyl 7-H, p-Bn, m-Ph),
6.98–6.85, (m, 6H; indolyl 6-H, o-Ph), 4.76 ppm (s, 2H; CH2); 13C NMR
(125 MHz, CDCl3): d=137.8, 132.9, 128.9, 128.4, 128.3, 127.8, 123.1,
120.8, 111.3, 104.3, 42.0 ppm (eight carbon signals missing or overlap-
ped); IR (film): n˜ =3343, 2962, 2924, 2853, 1697 cmꢀ1; MS (ES): m/z (%):
570 (100) [M++Na]; HRMS: m/z calcd for C39H28N3O2 [M++Na]:
570.2182; found: 570.2178.
(CH2)4CH2); 13C NMR (75 MHz, CDCl3): d=142.5, 137.0, 132.1, 130.4,
128.8, 128.5, 122.6, 121.2, 120.5, 111.1, 43.5, 29.4, 27.0, 26.8, 24.7 ppm
(four carbon signals missing or overlapped); IR (film): n˜ =2926, 2854,
1760, 1626 cmꢀ1; MS (ES) m/z (%): 641 (100) [M++Na]; HRMS: m/z
calcd for C42H38N2O3 [M++Na]: 641.2780; found: 641.2808.
23-Benzyl-26,27-dibenzyl-6,7,8,9,10,11,12,13,14,15-decahydro-22H-
5,25:16,21-dimethenodibenzo[b,h]pyrrolo[3,4-e,1,10]diazacycloicosine-
22,24-dione anti- and syn-18Bn: By using the same general method, the
bisindolylmaleimide 16Bn (50 mg, 0.084 mmol) and 1,10-dibromodecane
(19 ml, 0.084 mmol) gave a crude product that was purified by performing
flash chromatography, eluting with 15:85 diethyl ether/petroleum ether,
and preparative LC-MS, to give the macrocycle syn-18Bn (24 mg, 38%)
as a red film. Rf =0.36 (3:7 diethyl ether/petroleum ether); 1H NMR
(300 MHz, CDCl3): d=7.59 (d, J=7.8 Hz, 2H; indolyl 4-H), 7.34–7.23
(m, 11H; aromatic), 7.16 (td, J=7.4, 0.9 Hz, 2H; p-Ph), 7.09–7.05 (m,
4H; aromatic), 6.69–6.65 (m, 4H; aromatic), 4.82 (d, J=14.9 Hz, 1H;
NCHAPh), 4.76 (d, J=14.9 Hz, 1H; NCHBPh), 4.02–3.97 (m, 2H;
NCHA), 3.79–3.73 (m, 2H; NCHB), 3.76 (d, J=16.9 Hz, 2H; indolyl 2-
CHAHB), 3.30 (d, J=16.9 Hz, 2H; indolyl 2-CHAHB), 1.74–0.82 ppm (m,
16H); 13C NMR (75 MHz, CDCl3): d=171.6, 139.7, 138.6, 137.5, 133.1,
129.0, 128.8, 128.6, 127.8, 126.8, 126.2, 122.1, 121.0, 120.8, 110.4, 106.2,
77.6, 42.9, 42.1, 32.6, 28.1, 26.7, 26.6, 24.5 ppm (two carbon signals missing
or overlapped); IR (film): n˜ =2954, 1704, 1396 cmꢀ1; MS (ES) m/z (%):
736.3 (100) [M++H]; HRMS: m/z calcd for C51H49N3O2 [M++H]:
736.3903; found: 736.3911.
1-Benzyl-3,4-bis-(2-benzyl-1H-indol-3-yl)-pyrrole-2,5-dione (16Bn): The
crude product was purified by conducting flash chromatography, eluting
with 1:1 diethyl ether/petroleum ether and then EtOAc, to yield the bis-
indolylmaleimide 16Bn (1.37 g, 32%) as red/orange prisms. M.p. 270–
2728C (from EtOAc); Rf =0.32 (1:1 diethyl ether/petroleum ether);
1H NMR (300 MHz, CDCl3): d=7.80 (s, 2H; NH), 7.55 (d, J=7.2 Hz,
2H; indolyl 4-H), 7.42–6.70 (m, 21H; aromatic), 4.91 (s, 2H; CH2),
3.83 ppm (brs, 4H; 2PhCH2); 13C NMR (75 MHz, CDCl3): d=171.2,
139.2, 137.4, 137.1, 135.5, 131.7, 129.2, 128.9, 128.8, 128.7, 127.7, 126.9,
126.7, 122.2, 120.5, 110.7, 104.5, 42.0, 34.1 ppm (one carbon signal missing
or overlapped); IR (film): n˜ =3375, 3060, 1692, 1455, 1431, 1398,
741 cmꢀ1; MS (ES): m/z (%): 598.0 (100) [M++H]; HRMS: m/z calcd for
C41H31N3O2 [M++H]: 598.2495; found: 598.2509.
23-Benzyl-26,27-diphenyl-6,7,8,9,10,11,12,13,14,15-decahydro-22H-
5,25:16,21-dimethenodibenzo[b,h]pyrrolo[3,4-e,1,10]diazacycloicosine-
22,24-dione anti- and syn-18Ph: Sodium hydride (60% dispersion in
mineral oil, 32 mg, 0.8 mmol) was added portionwise to a solution of the
bisindolylmaleimide (16Ph) (150 mg, 0.3 mmol) in DMF (12 mL) at 08C,
and the mixture was stirred at room temperature for 15 min.1,10-Dibro-
modecane (60 mL, 0.3 mmol) was added, the reaction mixture was stirred
for 6 h, then quenched by the addition of water (100 mL).Ethyl acetate
(150 mL) was added, the organic layers were washed with water (2
100 mL), dried (MgSO4) and evaporated under reduced pressure.Purifi-
cation was achieved by conducting flash column chromatography (gradi-
ent elution 20:80!35:65 diethyl ether/petroleum ether) to yield the mac-
Also obtained, after further preparative HPLC, was the macrocycle anti-
18Bn (anti, 8 mg, 13% yield) as a red film. Rf =0.42 (3:7 diethyl ether/
petroleum ether); 1H NMR (300 MHz, CDCl3): d=7.40–6.87 (m, 23H;
aromatic), 4.81 (s, 2H; NCH2Ph), 4.14 (d, J=16.7 Hz, 2H; indolyl 2-
CHAHB), 3.57 (d, J=16.7 Hz, 2H; indolyl 2-CHAHB), 3.91–3.86 (m, 2H;
2NCHAHB), 3.69–3.63 (m, 2H; 2NCHAHB), 1.65–0.80 ppm (m, 16H;
alkyl chain); 13C NMR (75 MHz, CDCl3): d=170.9, 137.6, 137.0, 128.5,
128.4, 128.1, 127.8, 127.3, 126.7, 126.3, 122.1, 121.4, 120.5, 109.4, 77.2,
43.7, 30.9, 28.9, 26.8, 24.7, 24.3 ppm (four carbon signals missing or over-
lapped); IR (film): n˜ =2926, 2855, 1701, 1419, 1395, 1347 cmꢀ1; MS (ES)
m/z (%): 736.2 (100) [M++H]; HRMS: m/z calcd for C51H49N3O2 [M+
+H]: 736.3903; found: 736.3922.
rocycle syn-18Ph (45 mg, 24%) as red cubes.Mp..304–306
8C (from
DMSO); Rf =0.2 (1:3 diethyl ether/petroleum ether); 1HNMR
(500 MHz, CDCl3): d=7.37–7.30 (m, 4H; indolyl 4-H, p-Ph), 7.29–7.19
(m, 9H; m-Ph, o-Bn, m-Bn, p-Bn), 7.17–7.10 (m, 4H; indolyl 5-H, indolyl
7-H), 6.92–6.86 (m, 6H; indolyl 6-H, o-Ph), 4.59 (s, 2H; CH2Bn), 4.16
2
2
(dt, J=14.6, 6.9 Hz, 2H; NCHA), 4.08 (dt, J=14.6, 6.9 Hz, 2H; NCHB),
1.43–1.33 (m, 4H; NCH2CH2), 1.26–1.23 (m, 4H; N(CH2)2CH2), 1.06–
0.90 (m, 4H; N(CH2)3CH2), 0.86–0.68 ppm (m, 4H; N(CH2)4CH2);
13C NMR (75 MHz, CDCl3): d=170.7, 141.6, 137.6, 137.4, 137.1, 136.6,
132.7, 130.9, 129.9, 127.8, 127.1, 122.5, 121.9, 120.7, 111.2, 105.8, 43.8,
41.8, 28.9, 27.4, 27.1, 25.1 ppm (two carbon signals missing or overlap-
ped); IR (film): n˜ =2928, 2855, 1704, 1545 cmꢀ1; MS (ES): m/z (%): 708
(100) [M++H]; HRMS: m/z calcd for C49H45N3O2 [M++H]: 708.3590;
found: 708.3599.
Acknowledgements
We thank EPSRC and the University of Leeds for funding, the EPSRC
National Mass Spectrometry Centre, Swansea, for mass spectrometry
measurements, Stuart Warriner, Julie Fisher and Andrew Leach for help-
ful discussions, and Jacqueline Colley for HPLC analysis.
Also obtained was the macrocycle anti-18Ph (10 mg, 5% yield); Rf =0.3
1
(1:3 diethyl ether/petroleum ether); H NMR (500 MHz, CDCl3): d=7.44
(d, J=7.8 Hz, 2H; indolyl 4-H), 7.36 (t, J=7.5 Hz, 2H; p-Ph), 7.35–7.27
(m, 2H; Bn), 7.24–7.22 (m, 3H; Bn), 7.12 (appt, J=7.8 Hz, 2H; indolyl
7-H), 6.95–6.87 (m, 6H; H-5, m-Ph), 6.73–6.64 (m, 6H; indolyl 6-H, o-
Ph), 4.85 (d, 2J=14.9 Hz, 1H; CHABn), 4.81 (d, 2J=14.9Hz, 1H;
CHBBn), 3.89–3.84 (m, 2H; NCHAHB), 3.64–3.61 (m, 2H; NCHAHB),
2.19–2.14 (m, 2H; NCH2CH2), 2.12–1.86 (m, 2H; NCH2CH2), 1.64–1.04
(m, 8H; N(CH2)2CH2, N(CH2)3CH2), 0.88–0.65 ppm (m, 4H; N-
(CH2)4CH2); IR (film): n˜ =2928, 2855, 1704, 1545 cmꢀ1; MS (ES) m/z
(%): 708 (100) [M++H]; HRMS: m/z calcd for C49H45N3O2 [M++H]:
708.3590; found: 708.3598.
[1] For reviews, see: a) U.T.Rueegg, G.M.Burgess, Trends Pharmacol.
Sci. 1989, 10, 218; b) S.Omura, Y.Sasaki, Y.Iwai, H.Takeshima,
Antibiot. 1995, 48, 535.
J.
[2] a) L.M.Toledo, N.B.Lydon,
Structure 1997, 5, 1551; b) L.Prade,
R.A.Engh, A.Girod, V.Kinzel, R.Hube, D.Bossemeyer,
Structure
1997, 5, 1627; c) M.A. Lawrie, E.M. Noble, P. Tunnah, N.R.
Brown, L.N.Johnson, J.A.Endicott, Nat. Struct. Biol. 1997, 4, 796;
d) Z.Zhu, J.L.Kim, J.R.Newcomb, P.E.Rose, D.R.Stover, L.M.
Toledo, H.Zhao, K.A.Morgenstern,
Structure 1999, 7, 651; e) B.
Zhao, M.J.Bower, P.J.McDevitt, H.Zhao, S.T.Davis, K.O.Johan-
Also observed was the anhydride 26,27-diphenyl-6,7,8,9,10,11,12,13,14,15-
decahydro-22H-5,25:16,21-dimethenodibenzo[b,h]pyrrolo[3,4-e,1,10]di-
azacycloicosine-22,24-dione (12 mg, 6% yield) as yellow prisms.Mp..
265–2708C (from CHCl3); Rf =0.90 (CH2Cl2); 1H NMR (500 MHz,
CDCl3): d=7.41–7.30 (m, 4H; indolyl 4-H, p-Ph), 7.33 (appt, J=7.6 Hz,
4H; m-Ph), 7.26–7.24 (m, 2H; indolyl 7-H), 7.21 (appt, J=7.6 Hz, 2H;
indolyl 5-H), 6.95 (appt, J=7.6 Hz, 2H; indolyl 6-H), 6.90 (m, 4H; o-
Ph), 4.19 (dt, 2J=14.0, 6.0 Hz, 2H; NCHA), 4.02 (dt, 2J=14.0, 6.0 Hz,
2H; NCHB), 1.64–1.49 (m, 4H; NCH2CH2), 1.48–1.18 (m, 4H; N-
(CH2)2CH2), 1.09–0.90 (m, 4H; N(CH2)3CH2), 0.89–0.64 ppm (m, 4H; N-
son, S.M.Green, N.O.Concha, B.-B.S.Zhou,
277, 46609; f) A.Ogawa, Y.Takayama, H.Sakai, K.T.Chong, S.
Takeuchi, A.Nakagawa, S.Nada, M.Okada T.Tsukihara,
Chem. 2002, 277, 14351.
J. Biol. Chem. 2002,
J. Biol.
[3] a) RA. .Bit, PD. .Davis, LH. .Elliott, W.Harris, CH. .Hill, E.
Keech, G.Kumar, A.Maw, J.S.Nixon, D.R.Vessey, J.Wadsworth,
S.E.Wilkinson, J. Med. Chem. 1993, 36, 21; b) D.Toullec, P.Pianet-
ti, H.Coste, P.Bellevergue, T.Grand-Perret, M.Ajakane, V.
Baudet, P.Boissin, E.Boursier, F.Loriolle, L.Duhamel, D.Charon,
J.Kirilovsky, J. Biol. Chem. 1991, 266, 15771.
6284
ꢀ 2005 Wiley-VCH Verlag GmbH & Co.KGaA, Weinheim
Chem. Eur. J. 2005, 11, 6277 – 6285